News

Demystifying AI In Pharma

Demystifying AI In Pharma

Life Science Leader published an article by EVQLV's CEO, Andrew Satz, on how AI can be used in pharma to automate, analyze, or accelerate tasks as well as how to leverage AI to assist and augment team members. Written for leaders in the biotech and pharmaceutical...

read more
Andrew Satz on the Talent Finders Podcast

Andrew Satz on the Talent Finders Podcast

EVQLV's CEO, Andrew Satz, joined Kerrin Black of the Talent Finders Podcast to discuss his entrepreneurial journey, some of the challenges facing AI for drug discovery, his legacy and much more. Give it a listen below. https://youtu.be/A2QoFVnD1Wc Timestamps: Andrew's...

read more
Biotech vs COVID-19

Biotech vs COVID-19

BioIDEA and EVQLV are hosting a panel discussion and Q&A on the role of emerging technologies in the fight against COVID-19. Join us on Thursday, 5/14 at 4 PM EST for a panel discussion on the role of emerging technologies in the fight against COVID-19. If you'd...

read more
EVQLV Wins Columbia Venture Competition

EVQLV Wins Columbia Venture Competition

EVQLV is excited to announce we took first place in Columbia Engineering's Venture Competition (CVC). We've included a snippet from the announcement below. If you'd like to read the official release, you can do so here. In the Technology Challenge, avoMD and EVQLV...

read more

Pin It on Pinterest